CVS Stock Is Rising. A Wall Street Upgrade Helps Keep the Momentum Going. Shares of CVS Health were rising Thursday after the ...

Baird upgraded CVS Health (CVS) to Outperform from Neutral with a price target of $82, up from $71. The firm has growing confidence in a turnaround at the company’s Health Care Benefits segment ...

More than a dozen Rite Aid locations across Oregon will become CVS pharmacies by the end of September as the smaller chain ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $78.33, with a high estimate of $82.00 and a low estimate of $67.00. Marking an increase of 2 ...

Through the power of strategic, well-built partnerships, CVS Health helps employees earn degrees — and at no cost to them.

The company is also in talks to buy the pharmacy data from more locations, swapping over prescriptions to the nearest CVS.

CVS Health raised its full-year profit forecast after exceeding Wall Street quarterly earnings estimates on Thursday, as ...

CVS Health topped Wall Street expectations for the second quarter and it's hiking its full-year forecast again, as the health ...